Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2006-08-22
2006-08-22
Nguyen, Dave Trong (Department: 1633)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C424S093210, C435S320100, C435S069100, C435S455000, C435S456000, C536S023200, C536S024100
Reexamination Certificate
active
07094398
ABSTRACT:
The present invention provides for novel chimeric Ad-vectors carrying transgene, or portions of transgenes for stable and efficient gene transfer into diverse cell types or tissues in a CAR- and/or αυβ3/5-independent manner. Also provided are methods for producing such vectors and the use thereof for gene therapy to target a specific cell type or tissue.
REFERENCES:
patent: 5856152 (1999-01-01), Wilson et al.
patent: WO94/06920 (1994-03-01), None
patent: WO97/38723 (1997-10-01), None
patent: WO98/54346 (1998-12-01), None
patent: WO 00/70071 (2000-11-01), None
Davison et al, Genetic content and evolution of adenoviruses, Journal of General Virology, 2003, vol. 84, pp. 2895-2908.
Chow and Broker, The spliced structures of adenovirus 2 fiber message and the other late mRNAs, Cell, Oct. 1978, vol. 15(2), pp. 497-510.
Alexander, Ian E. et al., “DNA-Damaging Agents Greatly Increase the Transduction of Nondividing Cells by Adeno-Associated Virus Vectors,”Journal of Virology, 68:8282-7, 1994 (Exhibit 5).
Alexander, Ian E. et al., “Effects of Gamma Irradiation on the Transduction of Dividing and Nondividing Cells in Brain and Muscle of Rats by Adeno-Associated Virus Vectors,”Human Gene Therapy, 7:841-50, 1996 (Exhibit 6).
Antoniou, Michael et al., “Efficient 3′-end formation of human β-globin mRNAin vivorequires sequences with the last intron but occurs independently of the splicing reaction,”Nucleic Acids Research, 26:721-9, 1998 (Exhibit 7).
Balagué, Cristina et al., “Adeno-Associated Virus Rep78 Protein and Terminal Repeats Enhance Integration of DNA Sequences into the Cellular Genome,”Journal of Virology, 71:3299-306, 1997 (Exhibit 8).
Balagué, Cristina et al., “Sustained high-level expression of a full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector,”Blood, 95:820-8, 2000 (Exhibit 9).
Bhatia, Mickie et al., “A newly discovered class of human hematopoeitic cells with SCID-repopulating activity,”Nature Medicine, 4:1038-45, 1998 (Exhibit 10).
Becker, Pamela S. et al., “Adhesion receptor expression by hematopoietic cell lines and murine progenitors: Modulation by cytokines and cell cycle status,”Experimental Hematology, 27:533-41, 1999 (Exhibit 11).
Bergelson, Jeffrey M. et al., “Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5,”Science, 275:1320-3, 1997 (Exhibit 12).
Berns, Kenneth I., “Pavoviridae: The Viruses and Their Replication,”Fields Virology, 3rdEdition, B.N. Fields et al. (eds.), Lippincott-Raven Publishers, PA, 2:2173-97, 1996 (Exhibit 13).
Blau, C. Anthony et al., “Fetal Hemoglobin in Acute and Chronic States of Erythroid Expansion,”Blood, 81:227-33, 1993 (Exhibit 14).
Boyer, Julie et al., “Adenovirus E4 34k and E4 11k Inhibit Double Strand Break Repair and Ar Physically Associated with the Cellular DNA-Dependent Protein Kinase,”Virology, 263:307-12, 1999 (Exhibit 15).
Bregni, M. et al., “Adenovirus vectors for gene transduction into mobilized blood CD34+cells,”Gene Therapy, 5:465-72, 1998 (Exhibit 16).
Burcin, Mark M. et al. “Adenovirus-mediated regulable target gene expressionin vivo,” Proc Natl Acad Sci USA,96:355-60, 1999 (Exhibit 17).
Byk, Tamara et al., “Lipofectamine and Related Cationic Lipids Strongly Improve Adenoviral Infection Efficiency of Primitive Human Hematopoietic Cells,”Human Gene Therapy,9:2493-502, 1998 (Exhibit 18).
Cantwell, Mark J. et al., “Adenovirus Vector Infection of Chronic Lymphocytic Leukemia B Cells,”Blood, 88:4676-83, 1996 (Exhibit 19).
Case, Scott S. et al., “Stable transduction of quiescent CD34+CD38−human hematopoietic cells by HIV-1-based lentiviral vectors,”Proc Natl Acad Sci USA, 96:2988-93, 1999 (Exhibit 20).
Cerami, Carla et al., “The Basolateral Domain of the Hepatocyte Plasma Membrane Bears Receptors for the Circumsporozoite Protein ofPlamsodium falciparumSporozoites,”Cell,70:1021-33, 1992 (Exhibit 21).
Challberg, Sharon S. and Gary Ketner, “Deletion Mutants of Adenovirus 2: Isolation and Initial Characterization of Virus Carrying Mutations Near the Right End of the Viral Genome,”Virology, 114:196-209, 1981 (Exhibit 22).
Chartier, C. et al., “Efficient Generation of Recombinant Adenovirus Vectors by Homologous Recombination inEscherichia coli,” Journal of Virology, 70:4805-10, 1996 (Exhibit 23).
Chatterjee, Shyama et al., “A Conserved Peptide Sequence of thePlasmodium falciparumCircumsporozoite Protein and Anitpeptide Antibodies InhibitPlasmodium bergheiSporozoite Invasion of Hep-G2 Cells and Protect Immunized Mice againstP. bergheiSporozoite Challenge,”Infection and Immunity, 63:4375-81, 1995 (Exhibit 24).
Chen, Hsiaoli et al., “Analysis of enhancer function of the HS-40 core sequence of the human α-globin cluster,”Nucleic Acids Research, 25:2917-22, 1997 (Exhibit 25).
Chillon, Miguel et al., “Group D Adenoviruses Infect Primary Central Nervous System Cells More Efficiently than Those from Group C,”Journal of Virology, 73:2537-40, 1999 (Exhibit 26).
Chroboczek, J. et al., “Adenovirus Fiber,”Current Topics in Microbiology and Immunology, W. Doerfler and P. Böhm (eds.), Springer, 1:163-200, 1995 (Exhibit 27).
Chung, Jay H. et al., “Characterization of the chicken β-globin insulator,”Proc Natl Acad Sci USA, 94:575-80, 1997 (Exhibit 28).
Crompton, Janet et al., “Expression of a foreign epitope on the surface of the adenovirus hexon,”The Journal of General Virology, 75:133-9, 1994 (Exhibit 29).
Dao, Mo A. et al., “Engraftment and Retroviral Marking of CD34+and CD34+CD38−Human Hematopoietic Progenitors Assessed in Immune-Deficient Mice,”Blood, 91:1243-55, 1998 (Exhibit 30).
Davison, A. J. et al., “The DNA Sequence of Adenovirus Type 40,”Journal of Molecular Biology, 234:1308-16, 1993 (Exhibit 31).
Dayhoff, M. O. et al., “A Model of Evolutionary Change in Proteins,”Atlas of Protein Sequence and Structure, Supplement 3, 5:345-52, 1978 (Exhibit 32).
Defer, Christine et al., “Human Adenovirus-Host Cell Interactions: Comparative Study with Members of Subgroups B and C,”Journal of Virology, 64:3661-73, 1990 (Exhibit 33).
Doi, N. and H. Yanagawa, “Screening of comformationally constrained random polypeptide libraries displayed on a protein scaffold,”Cellular and Molecular Life Sciences, 54:394-404, 1998 (Exhibit 34).
Dunaway, Marietta et al., “The Activity of the scs and scs' Insulator Elements Is Not Dependent on Chromosomal Context”,Molecular and Cellular Biology, 17:182-9, 1997 (Exhibit 35).
Ellerby, H. Michael et al., “Anti-cancer activity of targeted pro-apoptotic peptides,”Nature Medicine, 5:1032-8, 1999 (Exhibit 36).
Ellis, James et al., “A dominant chromatin-opening activity in 5′ hypersensitive site 3 of the human β-globin locus control region,”The EMBO Journal, 15:562-8, 1996 (Exhibit 37).
Ellis, James et al., “Evaluation of β-globin gene therapy constructs in single copy transgenic mice,”Nucleic Acid Research, 25:1296-302, 1997 (Exhibit 38).
Emery, David W. et al., “Analysis of γ-Globin Expression Cassettes in Retrovirus Vectors,”Human Gene Therapy, 10:877-888, 1999 (Exhibit 39).
Everitt, E. and E. Rodríguez, “Adenovirus cellular receptor site recirculation of HeLa cells upon receptor-mediated endocytosis is not low pH-dependent,”Archives of Virology, 144:787-95, 1999 (Exhibit 40).
Felsenfeld, Gary et al., “Chromatin structure and gene expression,”Proc Natl Acad Sci USA, 93:9384-8, 1996 (Exhibit 41).
Fiering, Steven N. et al., “Improved FACS-Gal: Flow Cytometric Analysis and Sorting of Viable Eukaryotic Cells Expressing
Farrer Denise R
Lieber Andre
Papayannopoulou Thalia
Shayakhmetov Dmitry M
Stamatoyannopoulos George
Nguyen Dave Trong
Townsend and Townsend / and Crew LLP
University of Washington
LandOfFree
Recombinant adenoviral vectors expressing chimeric fiber... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant adenoviral vectors expressing chimeric fiber..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant adenoviral vectors expressing chimeric fiber... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3614063